Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine-Reference-Cited by-同舟云学术

Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine

Published:2021-01 Issue:1 Volume:23 Page:21-35
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Rivera Maria,Fichtner Iduna,Wulf-Goldenberg Annika,Sers Christine,Merk Johannes,Patone Giannino,Alp Keziban M.^ORCID,Kanashova Tamara,Mertins Philipp,Hoffmann Jens,Stein Ulrike,Walther Wolfgang^ORCID

Funder

the OncoPath consortium of the Federal Ministry of Education and Research, Germany

Publisher

Elsevier BV

Subject

Cancer Research

Reference57 articles.

1. Colorectal cancer statistics;Siegel;CA Cancer J Clin,2020

2. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

3. The cancer genome;Stratton;Nature,2009

4. Cancer treatment and survivorship statistics;De Santis;CA Cancer J Clin,2014

5. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor;Saltz;J Clin Oncol,2004

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Near-infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Patient-Derived Xenografts Using a Humanized Anti-Fibroblast Activation Protein Antibody;Molecular Cancer Therapeutics;2024-04-18

2. A Case Study of a Rare Undifferentiated Spindle Cell Sarcoma of the Penis: Establishment and Characterization of Patient-Derived Models;Genes;2024-03-28

3. Patient-Derived Xenografts: A Valuable Preclinical Model for Drug Development and Biomarker Discovery;Methods in Molecular Biology;2024

4. Patient‐Derived Microphysiological Systems for Precision Medicine;Advanced Healthcare Materials;2023-12-10

5. Establishment and Thorough Characterization of Xenograft (PDX) Models Derived from Patients with Pancreatic Cancer for Molecular Analyses and Chemosensitivity Testing;Cancers;2023-12-08